Open access · CC-BY
via OpenAlex
Lens epithelial cells senescence in cataract pathogenesis and emerging therapeutic opportunities
Liangning Cui, Yiyi Wang, L. A. Wang, Jianhao Bai, Wanru Zhou, Manhui Zhu, Jie Zhou, Haiying Jin
Frontiers in Cell and Developmental Biology · 2026 · ▲ 1 citations
Abstract
Lens epithelial cells (LECs) senescence(definition) is a central pathogenic mechanism in cataract formation, driven by a variety of chronic stressors such as oxidative damage, UV radiation, metabolic disturbances, and mechanical strain. When exposed to these stressors, LECs undergo a series of cellular responses, including stable cell cycle arrest, development of a senescence-associated secretory phenotype (SASP), and impaired autophagic flux. These alterations compromise the function of LECs, disrupt lens homeostasis, and promote the pro-inflammatory microenvironment that accelerates cataract progression. Recent advances in targeting senescent LECs have led to the development of promising pharmacological therapies, including senolytics(definition) and senomorphics. Senolytic agents, such as Dasatinib and Quercetin, selectively eliminate senescent cells, while senomorphic agents like Metformin and mTOR(definition)-inhibiting drug studied for extending healthspan and lifespan." style="text-decoration:underline dotted; text-underline-offset:2px; cursor:help;">Rapamycin(definition) aim to modulate the senescence-associated secretory phenotype and restore cellular homeostasis. Despite these promising results, challenges remain, particularly in overcoming ocular drug delivery barriers. Nonetheless, the potential of targeting LECs senescence offers new therapeutic opportunities for cataract management. Collectively, these insights support a paradigm shift in cataract management. Rather than relying solely on surgical intervention, future strategies may emphasize biologically informed, disease-modifying, and preventive approaches that target cellular senescence.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3389/fcell.2026.1758898
- Canonical
- link ↗
- Fetched
- 2026-11-11 MST
Cite this
APA
Cui, L., Wang, Y., Wang, L.A., Bai, J., Zhou, W., Zhu, M., Zhou, J., & Jin, H. (2026). Lens epithelial cells senescence in cataract pathogenesis and emerging therapeutic opportunities. <em>Frontiers in Cell and Developmental Biology</em>. https://doi.org/10.3389/fcell.2026.1758898
Vancouver
Cui L, Wang Y, Wang LA, Bai J, Zhou W, Zhu M, et al. Lens epithelial cells senescence in cataract pathogenesis and emerging therapeutic opportunities. Frontiers in Cell and Developmental Biology. 2026. doi:10.3389/fcell.2026.1758898.
BibTeX
@article{liangning2026Lensep,
title = {Lens epithelial cells senescence in cataract pathogenesis and emerging therapeutic opportunities},
author = {Liangning Cui and Yiyi Wang and L. A. Wang and Jianhao Bai and Wanru Zhou and Manhui Zhu and Jie Zhou and Haiying Jin},
journal = {Frontiers in Cell and Developmental Biology},
year = {2026},
doi = {10.3389/fcell.2026.1758898},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Advances in Translational Research 2026
Open access · CC-BY
Senotherapeutics: Emerging pharmacological strategies to target cellular senescence
Pharmaceuticals 2025
Open access · CC-BY
Cellular Senescence in Health, Disease, and Lens Aging
Preprints.org 2025
Preprint · CC-BY
Cellular Senescence in Health, Disease, and Lens Aging
Med-X 2026
Open access · CC-BY
Modulating senescence for therapeutic delivery
International Journal of Sciences and Innovation Engineering 2025
Open access · CC-BY
Pharmacology of Senolytics: Targeting Cellular Aging in Chronic Diseases
Biomedicines 2026
Open access · CC-BY